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a b s t r a c t
The photodynamic therapy (PDT) is a combination of using a photosensitizer agent, light and oxygen that
can cause oxidative cellular damage. This technique is applied in several cases, including for microbial
control. The most extensively studied light sources for this purpose are lasers and LED-based systems.
Few studies treat alternative light sources based PDT. Sources which present ﬂexibility, portability and
economic advantages are of great interest. In this study, we evaluated the in vitro feasibility for the
use of chemiluminescence as a PDT light source to induce Staphylococcus aureus reduction. The Photo-
gem concentration varied from 0 to 75 lg/ml and the illumination time varied from 60 min to 240 min. -
The long exposure time was necessary due to the low irradiance achieved with chemiluminescence
reaction at lW/cm2 level. The results demonstrated an effective microbial reduction of around 98% for
the highest photosensitizer concentration and light dose. These data suggest the potential use of chemi-
luminescence as a light source for PDT microbial control, with advantages in terms of ﬂexibility, when
compared with conventional sources.
 2011 Elsevier B.V. All rights reserved.
1. Introduction
Photodynamic therapy (PDT) is a technique which, besides its
application in cancer treatment, has also shown promising results
for in situ treatment of infected lesions [1]. The PDT indication for
such application has been demonstrated by several authors [2–4],
employing different combinations of microorganisms and photo-
sensitizers. The photodynamic reaction is induced after an interac-
tion of a photosensitizer (PS) and light in the presence of oxygen.
The essential point of photodynamic action is the illumination of
the target tissue, previously photosensitized, resulting in PS excita-
tion, and in a sequence of events, including singlet oxygen produc-
tion, which induces a local toxicity [5,6].
The appearance of bacteria species which are resistant to anti-
biotics drugs, raised the need to establish and improve other sys-
tems of microbial control. PDT is one of the alternative
procedures and based on its mechanisms, it is not likely that
microorganisms develop resistance [7,8].
As for tumor treatment, PDT for microbial control also relies on
induced cell killing. In the case of bacteria photosensitization, the
cellular targets of PDT sensitizers have been cellular membranes
and nucleic acids, depending on PS physic-chemical properties [2].
For most PDT applications the appropriate light source consti-
tutes the main limitation. Illumination parameters as wavelength,
irradiance and ﬂuence are essential for the appropriate PS excita-
tion and cellular killing. The matching of the excitation spectrum
with, at least, one of the absorption band of the PS is need for
the photodynamic response. For the treatment of infected lesions,
it is also important to establish a PDT protocol that results in
microorganism killing but is safe to human cells.
Several types of light sources have been employed in PDT pro-
tocols, including lasers, lamps and LED-based systems. Those light
sources are distinct when considering certain parameters, i.e. spec-
tral emission, collimation/divergence and optical coupling. These
light sources are electricity-dependent systems and therefore
may not be fully portable. Laser systems are widely used due to
their spectral characteristics, light energy concentration, and the
best optical ﬁber coupling, when compared to the other sources.
Laser sources are so far the ﬁrst option for the PDT treatment of
internal organs as in esophagus, lung and bladder cancers. There
are already some portable light sources based on battery, powered
systems for PDT treatments [9,10].
Unfortunately, even though the cost of a PDT laser equipment
has been decreasing, it remains a prohibitive factor for a large scale
acquisition, especially in developing countries. LED-based systems,
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which are less expensive compared to lasers, have been presented
as an attractive light source option for the treatment of skin and
oral lesions where the access of the illumination tip is direct.
Both light sources, lasers and LEDs, show advantages and disad-
vantages when considering their applications, but there is still
room for instrumentation of non-electrical light source. Some
countryside regions, located far from metropolitan areas, are not
provided with well-equipped clinical facilities, and in several cases
there is not even electricity. Homecare treatment is also an exam-
ple where a non-wired PDT system can be used and is actually re-
quired, especially when patient’s convenience is taken into
consideration. The possibility for more practical light sources
may even make the introduction of new PDT procedures possible.
Chemiluminescence (CL) stands for a chemical reaction which
results in light emission [11–14]. Depending on the reagents of
the chemical reaction, the emission wavelength can be tuned.
Although chemiluminescence shows a very low intensity emission
when compared to the available PDT light sources, its emission
may be sufﬁcient for microbial control in infected lesions. The
use of chemiluminescence combined to PDT action is a topic not
yet widely explored and its main principles still remain to be
demonstrated.
Chemiluminescence is a chemical reaction that results in light
emission, completely independent on electricity. There are distinct
CL reactions as the oxidation of luminal or luciferin and the perox-
yoxalate system. The reactants used in the reaction determine the
optical characteristics of the emitted light, including spectrum,
intensity an lifetime. The mechanism of the CL reaction was pro-
posed by Rauhut in 1967 describing the reaction of the peroxyox-
alate system [11–14].
The mixture is performed with an oxalate reactant of bis(2,4,6-
trichlorophenyl) (TCPO) in the presence of hydrogen peroxide
(H2O2) and an activador (ACT), in this case, 9,10-bis(phenyleth-
ynyl)anthracene (BPEA). This reaction occurs in a solution of imid-
azole (IMI-H) and ethyl acetate (EtOAc).
The TCPO reacts with the H2O2 producing a cyclic peroxide, a
highly energetic molecule that later reacts with the BPEA. A se-
quence of events, called Chemically Initiated Electron Exchange
Luminescence mechanism – CIEEL mechanism – is induced.
According to Rauhut, there is a highly energetic metastable inter-
mediated that reacts with the activation and constitutes one of
the main components for the CIEEL mechanism.
Current PDT studies have demonstrated the positive aspects of
the use of low irradiances during long-time illumination. This
could be one attempt to avoid the effect on the oxygenation system
in the illuminated area, due to a lower vasculature collapse and
thus getting improved results in photodynamic response. This kind
of analysis has been carried out by Seshadri, Bisland and Wilson,
where low doses (2 and 5 J/cm2), at an intensity of 10 mW/cm2
were able to reduce some types of bacteria using long exposure
time [15–22]. To the best of our knowledge, no studies have been
performed for the investigation of the PDT efﬁcacy when operating
on an irradiance level of lW/cm2.
Another factor which must be considered when low irradiances
are used, is that long illumination times are necessary. This fact
may turn into a drawback for an in-ofﬁce application, because of
an unfeasible long working time, but it may not be a problem for
a home treatment, if a suitable illumination device is developed.
Also, the possibility of a ﬂexible and portable non-wired device
with a spectral emission tunability regarding the chemical re-
agents, makes chemiluminescence a potential light source for anti-
microbial PDT.
The microbial control and bacterial reduction studies became
objects of great interest to public health, especially when these
microorganisms have been related to hospital infection, as the
Staphylococcus aureus [3,7,23–30]. Therefore, the development of
techniques for microbial control that are not antibiotic dependent
became very important [31,32] as shown by Meisel, Zeina, O’riodan
and Hasan where they veriﬁed that an infection control using dif-
ferent types of photosensitizers (methylene blue, rose bengal, chlo-
rophyll, phthalocyanines and others) were effective on both Gram
negative and Gram positive microorganisms, e.g. Candida albicans,
Porphyromonas gingivalis, Staphylococcus epidermidis and S. aureus.
In general, the development of techniques that do not induce bac-
terial resistance is of great relevance [7,30].
In this sense, the aim of this study was to evaluate in vitro the
feasibility of chemiluminescence as a light source for PDT on Staph-
ylococcus aureus growth reduction.
2. Materials and methods
2.1. Bacterial culture
S. aureus (American Type Culture Collection – ATCC 25923) was
chosen as a ﬁrst microbial target, since it is the most common spe-
cies of hospital infections. The bacterial culture was aerobically
grown overnight at 37 C in 5 ml of Tryptic Soy Broth (TSB) (Acu-
media Manufactures Inc., Lansing, USA). The culture was harvested
after centrifugation at 2000 rpm for 10 min, washed twice with
sterile distilled water and resuspended in sterile saline to a turbid-
ity of 106 cells ml1, determined by a spectrophotometer BioPho-
tometer (Eppendorf AG, Hamburg, Germany) set at 600 nm.
2.2. Photosensitizing agent (PS)
The PS used in this study was Photogem (Photogem, Moscow,
Russia) a ﬁrst generation PDT sensitizer, a mixture of monomeric,
dimers and oligomers of porphyrin units, with similar properties
compared to Photofrin [1,2]. Photogem was chosen as the PS
due to the previously presented results on bacteria growing control
[28]. Fig. 1 presents the chemical structure of dimeric form of the
Photogem. Solutions were prepared by diluting Photogem pow-
der in sterile saline and protecting from light exposure. Four sensi-
tizer concentrations were evaluated 6; 25; 50 and 75 lg/ml. These
concentrations were determined after a previous experiment,
where a high dark toxicity was observed for PS concentration of
150 lg/ml (results not shown).
2.3. Light source
A volume of 30 ml of chemiluminescent solution were used for
each one hour of PDT illumination. The chemical reagents for CL
were obtained from 30 luminescent light sticks (Light Stick Ltd.,
Pequim, China) which present the following reagents: ethyl ace-
tate, 9,10-bis (phenylethynyl) anthracene; oxalate, bis (2,4,6-tri-
chlorophenyl) imidazole and hydrogen peroxide. The solution
was removed from the sticks and placed in a Petri dish with
5.0 cm diameter and 1.5 cm height, with the solution ﬁlling its
whole volume. This setup provided uniform illumination over the
area of 12 wells in a 96-well culture cell test plate. The CL solution
was replaced every 60 min, which corresponds to 2x of the half life
of the CL reaction, for a more uniform delivered light intensity dur-
ing all illumination time, for the groups with 120 and 240 min.
2.4. In vitro procedure
Aliquots of 100 ll of S. aureus suspension were individually
transferred to 12 wells of a 96-well test plate. An equal volume
of PS solutions was added to each well to achieve ﬁnal concentra-
tions of 6; 25; 50; and 75 lg/ml. The 2 min of dark incubation was
chosen based on another experiment [28] as where this time
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showed already good results. The 96-well plate was positioned
over a Petri dish containing 30 ml of the chemiluminescence solu-
tion. The CL solution was 40 mm distant from the bottom of the
cell culture plate. Illumination was performed for 60, 120 and
240 min, resulting in a total ﬂuence of 0.2, 0.4 and 0.8 J/cm2,
respectively.
To determine the dark toxicity of the PS itself, for each concen-
tration, the pre-photosensitized bacteria suspensions were pro-
tected from ambient and chemiluminescent illumination for all
tested times. The cytotoxicity effect of the chemiluminescence
for 60, 120 and 240 min was also investigated in bacteria suspen-
sions without PS exposure. The bacteria suspensions with neither
photosensitization, nor illumination, constituted the non-treated
control group.
Table 1 presents the experimental groups: (I) PS–L(no photo-
sensitizer, no light); (II) PS–L+(treated only with light); (III)
PS + L(treated only with photosensitizer), and (IV) PS + L+(PDT
treated).
After illumination, the bacteria survival rate was determined by
counting the number of bacterial colony forming units (c.f.u.). Seri-
ally diluted aliquots (101–103) of treated and untreated bacteria
were plated on Mannitol Salt Agar (Acumedia manufactures, Inc.,
Lansing, USA) using 25 ll aliquots. The number of c.f.u. was
counted after 48 h incubation at 37 C. Each serial dilution for each
group was performed in triplicate.
3. Results
Initial attention should be give to the optical properties of CL
and PS. The optical spectrum of CL emission was obtained using
a spectrophotometer (Spectral-Fluorescence System ‘‘Spectr-Clus-
ter’’ v. 2.05 m, Cluster Ltd., Moscow, Russia). This signal is shown
in Fig. 2 and reveals signiﬁcant intensity emitted between
450 nm and 600 nm with a peak at 505 nm and 34 nm FWHM.
The total optical intensity emitted by CL solution (30 ml) was still
monitored during 60 min using an optical power meter Field Mas-
ter (Coherent Inc., San Jose, USA) coupled to an optical sensor for
low level visible radiation (up to 50 mW). Inset of Fig. 2 shows this
result and depicts the temporal proﬁle of CL emission as a like-
exponential decay with close to 20 min decay time. At (t = 0), the
chemiluminescent reaction emits 100 ± 7 lW/cm2; with time the
temporal proﬁle of CL emission drives the behavior of light dose
delivered to cells-targets. In a PDT cycle (60 min) CL yielded round
to 0.2 J/cm2, which was sufﬁcient to cause a photodynamic action.
The absorption spectrum of the photosensitizer was further
examined in order to check the spectral region where the CL emis-
sion is a strongly absorbed by the PS solution. In fact, it is easy to
conclude that the efﬁcacy of the PDT treatment depends on the
overlapping between these spectra. Based on this concept, the
absorption spectrum of PS as well the emission spectrum of CL
was plotted, as shown in Fig. 3. Both spectra were normalized by
maximum peak intensity in order to focus on predominant spectral
information and this graph shows a strong overlap between CL
emission and PS absorption.
A correlation parameter (g) was deﬁned to represent the match-
ing between PS absorption and CL emission spectra (Eq. (1)).
g ¼
P600
i¼475EiAi
P600
i¼475AiAi
ð1Þ
where Ei is CL emission spectra and Ai is PS absorption spectra.
Since the correlation (g) between CL emission and PS absorption
can be used as a quantitative tool of overlapping, g was calculated
by performing the product of both spectra intensity at the same
wavelength and revealed the value of g chemiluminescence (gch)
is gch  0.5. We used two LED-devices LUXEON III (green LED,
LXHL-PM09; red LED, LXHL-PD09, Philips Lumileds Lighting Co.,
San Jose, USA) to compare the CL to other light sources. The emis-
sion spectra of both LED-devices are presented in Fig. 3 normalized
Fig. 1. Chemical structure of dimeric form of Photogem.
Table 1
Scheme of the organization per experimental group. Different photosensitizer
concentrations (6;25;50 and 75 lg/ml) were investigated in the experiments with
the presence of photosensitizer.
Group I Group II Group III Group IV
60 min Light No Yes No Yes
PS No No Yes Yes
120 min Light No Yes No Yes
PS No No Yes Yes
240 min Light No Yes No Yes
PS No No Yes Yes
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Fig. 2. Chemiluminescence emission spectrum and its decay time (inset).
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by the highest intensity. In a visual analysis it is easy to see the CL
emission to have a stronger overlap with PS absorption than for
other LED-devices. Despite this analysis, the correlation of LED
emission and Photogem absorption were performed and the re-
sults present values of gg  0.5 for green LED and gr  0.1 for red
LED. These values demonstrate that CL and green LED have similar
absorption efﬁciency, leading to conclude that chemiluminescence
could be an as effective light source as a commercial green LED to
induce the photoactivity of Photogem in a PDT treatment.
The microorganism survival after 60, 120 and 240 min without
Photogem sensitization, nor illumination, was evaluated for
group I (PS–L) in order to assure that the treatment times were
not inﬂuencing bacterial growth. No bacterial death was observed
up to 240 min, showing that S. aureus resisted at room tempera-
ture, at experimental conditions which no lack of nutrients was
found. Similar results were obtained for group II (PS–L+) when cells
were illuminated without the presence of PS. In this case, the
chemiluminescence has not shown any signiﬁcant effect on bacte-
rial growth for all investigated exposure times.
The dark toxicity of Photogem (group III; PS + L) was ana-
lyzed for different PS concentrations (6, 25, 50 and 75 lg/ml).
The results due to the in vitro incubation at 240 min are presented
in Fig. 4. While the PS concentrations up to 25 lg/ml did not induce
microorganism reduction, higher concentrations caused the men-
tioned toxicity effects. The maximum reduction rate was 22.6%
(log reduction < 0.1) at 240 min incubation and 75 lg/ml PS con-
centration. This reduction is not signiﬁcant when considering
microbial growth control. Even though these toxicity effects could
be tolerable, it indicates that higher PS concentrations must be
carefully managed in order to avoid undesirable effects on healthy
tissues. Nevertheless, these are concerns for future investigation.
The combined effect involving PS and light, the PDT effect was
evaluated with group IV (PS + L+) and it presented a signiﬁcant
bacterial reduction compared to group III. While the maximum
reduction rate induced by dark toxicity was 22.6%, with this same
240 min of illumination, the reduction rate induced by photody-
namic effect was near 60% for 6 lg/ml and 98% for 75 lg/ml Photo-
gem concentration. These reduction rates indicate that even with
use of lowest photosensitizer concentration, the PDT treatment is
three times more efﬁcient for microbial control than PS dark
toxicity.
In order to show details of group IV results, Fig. 5 depicts the
microbial reduction rate for all PDT subgroups. Fig. 5a presents
the percentage of c.f.u counting as a function of the light dose
and Fig. 5b presents the microbial population at logarithm scale
as a function of PS concentration. The results reveal that for a light
dose of 0.2 J/cm2 the bacterial reduction achieved was 3% (log
reduction < 0.01) using 6 lg/ml PS concentration and 84% (log
reduction < 0.8) using 75 lg/ml PS concentration. Increasing the
light dose to 0.8 J/cm2 the bacterial reduction achieved was 54%
(log reduction < 0.4) using 6 lg/ml PS concentration and 98% (log
reduction < 2) using 75 lg/ml PS concentration.
4. Discussion
It is possible to determine PDT protocols in accordance with the
PS concentration and the light dose. The bacterial reduction ob-
tained with 75 lg/ml concentration and 0.2 J/cm2 light dose is sim-
450 500 550 600 650 700 750 800
0.0
0.2
0.4
0.6
0.8
1.0
In
te
ns
ity
 (a
.u
.)
Wavelength (nm)
 Photogem absorption
 CL emission
 Green LED emission
 Red LED emission
Fig. 3. Light sources (CL, green LED and red LED) emission and photosensitizer
absorption at visible spectral range showing the spectra overlap.
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ilar to the one obtained with 25 lg/ml and 0.4 J/cm2 light dose.
This indicates that the PDT protocol using CL as a light source is
ﬂexible and the choice of parameters could be adapted to the pa-
tient’s condition. The same standard is observed between the pro-
tocols with 75 lg/ml and 0.4 J/cm2 and with 25 lg/ml and 0.8 J/
cm2. There is no direct correlation between the here tested PS con-
centrations and the potential concentration to be used at the clinic.
In an infected lesion the microorganisms are present in a bioﬁlm,
resulting in distinct PS and oxygen distributions. Based on our
experience, and also on several studies from other groups, we ex-
pect that both PS concentration and light dose needed for PDT re-
sponse in an infected lesion will be higher than the experimental
values determined in planktonic culture.
Besides, it should be pointed out that the microbial reduction
over 95% (log reduction  2) obtained using the PS concentration
of 50 or 75 lg/ml and 0.8 J/cm2 light dose are in accordance with
the results obtained with other conventional microbial reduction
techniques [8,25,28]. It is clear that a higher microorganism reduc-
tion can be obtained with the much higher light intensities
achieved with laser or LED sources, as presented by studies where
the log decrease is of 4–6 units [2,29,33]. We believe that this log
reduction range is difﬁcult to obtain using the chemiluminescence
as a light source. In order to achieve an antimicrobial effect, the
PDT protocol can be modiﬁed balancing the PS concentration and
light dose. In our study, to achieve higher log reduction units, the
PS concentration would have to increase over 75 lg/ml, but in this
case, the PS dark toxicity begins to be relevant. Even though the
microbial reduction was about 2 log units, the possibility of the
application of multiple PDT sessions may overcome this limitation.
Based on the concept of a CL-PDT for a home treatment this can be
feasible. A home treatment for infectious lesions is attractive for
health policies of country communities and small towns without
hospital facilities.
The goal of this in vitro study was to demonstrate the efﬁcacy of
the light generated by a chemiluminescent reaction as a light
source for photodynamic therapy applied to microbial control.
The idea of a portable, ﬂexible and low cost light source based on
chemiluminescence shows a potential clinical use.
The results presented in this paper demonstrated the feasibility
of applying this technique for in vivo studies, even though the PS
and light parameters may change for tissue application. For all
investigated protocols, the chemiluminescence effectiveness for
PDT can be observed (group IV). The other groups (I, II and III)
showed that there is no relevant bacterial reduction in the absence
of either photosensitizer or light.
Under the presented experimental conditions, two important
behaviors were veriﬁed. Firstly, the higher is the PS concentration,
the smaller is the importance of illumination time. Secondly, the
longer the illumination, the smaller the importance of the photo-
sensitizer concentration in presented experimental conditions.
Chemiluminescence showed itself as being a potential light source
for microbial control; however, further investigations are neces-
sary and will be the topic of future studies.
The light intensity decreases as a function of time, a behavior
that is related to the CL reaction. We chose to replace the CL solu-
tion every 60 min for the groups with 1 and 2 h of illumination. The
decrease in intensity affects the overall PDT, effect since it modiﬁes
the delivered energy. In this ﬁrst study we aimed to determine the
CL efﬁciency as PDT light source, in further experiments it may be
possible to assemble a device where the CL solution is continu-
ously replaced to overcome this intensity decrease issue.
The light intensity provided by the CL reaction decreases con-
tinuously as a function of time. The initial value for our setup is
of 100 lW/cm2 and the observed decay is ruled by an exponential
equation. In this way, after 20 min of reaction, the intensity is
around 50 lW/cm2. After 60 min of reaction, the solution was re-
placed by a new one. This non-uniform intensity during the whole
experiment has inﬂuence on the dosimetry and also on the ﬁnal
PDT response. Even though this is not ideal for the PDT response,
we still wanted to test its overall efﬁcacy on the microbial
reduction.
The inactivation efﬁcacy would be indeed improved if the illu-
mination time for each CL solution was of 10 min, but in this exper-
iment we aimed to evaluate the efﬁcacy of the total reaction.
Improvements can be done if we use a 10 min time of CL
replacement.
We believe that a CL source for clinical PDT could be a transpar-
ent and ﬂexible bag ﬁlled with the CL reactants. The CL reaction
would be initiated just before its placement on the target tissue
after the breaking of small glass tubes containing the reactants.
The treatment time for each bag must be previously determined
based on the half lifetime of the CL reaction. If needed, the CL
bag can be replaced for new ones until the total light dose is deliv-
ered to the target tissue.
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